Nina Capital

www.nina.capital

VCMatch tracks Nina Capital as an investor focused on Healthtech, Digital Health, and AI/ML companies, Pre-Seed and Seed rounds, Europe, Pan European, and United Kingdom markets, and $200k to $1.5m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$200k to $1.5m

Stages

Pre-Seed, Seed, Series A

Focus Areas

Healthtech, Digital Health, AI/ML

Geography

Europe, Pan-European, and United Kingdom

Investment Thesis

NINA Capital invests exclusively at the intersection of healthcare and technology, guided by the Stanford Biodesign methodology of health technology innovation. They believe in a need-driven, value-based approach to healthcare transformation, confident that ‘need-driven technology ventures generate the highest value in healthcare and for their investors.’ Their philosophy centers on backing thoughtful, committed founders who combine deep understanding of healthcare system complexity with meaningful engineering innovation and advanced data science.

Is Nina Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Nina Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Healthtech, Digital Health, AI/ML, and Data Infrastructure, especially across Europe, Pan-European, and United Kingdom, with public check-size signals around $200k to $1.5m.

Focus statement

NINA Capital invests in healthcare transformation powered by information technology and led by need-driven founders. They focus on pre-seed to seed+ stages with ticket sizes from €200k to €1.5M across pan-European, US, Canadian, Israeli, and Australian markets.

Value Add

Specialized focus exclusively on healthcare-technology intersection with Biodesign methodology foundation
Need-driven founder requirement - founders must have deep understanding of healthcare unmet needs
Pan-European headquarters with international ambitions requirement for portfolio companies
Explicit exclusion of drugs and vaccines, focusing on healthcare tools and digital solutions
Strong emphasis on team diversity and multidisciplinary composition as investment criterion
Collaborative approach to syndication - founders choose their partners rather than NINA controlling the syndicate
Founded by Stanford faculty member with deep healthcare innovation expertise
Integration of sustainability and ESG criteria throughout investment process